Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice.
Intrauterine environmental pertubations have been linked to the development of adult hypertension. We sought to evaluate the interrelated roles of sex, nitric oxide, and reactive oxygen species (ROS) in programmed cardiovascular disease. Programming was induced in mice by maternal dietary intervention (DI; partial substitution of protein with carbohydrates and fat) or carbenoxolone administration (CX, to increase fetal glucocorticoid exposure). Adult blood pressure and locomotor activity were recorded by radiotelemetry at baseline, after a week of high salt, and after a week of high salt plus nitric oxide synthase inhibition (by l-NAME). In male offspring, DI or CX programmed an elevation in blood pressure that was exacerbated by N(omega)-nitro-l-arginine methyl ester administration, but not high salt alone. Mesenteric resistance vessels from DI male offspring displayed impaired vasorelaxation to ACh and nitroprusside, which was blocked by catalase and superoxide dismutase. CX-exposed females were normotensive, while DI females had nitric oxide synthase-dependent hypotension and enhanced mesenteric dilation. Despite the disparate cardiovascular phenotypes, both male and female DI offspring displayed increases in locomotor activity and aortic superoxide production. Despite dissimilar blood pressures, DI and CX-exposed females had reductions in cardiac baroreflex sensitivity. In conclusion, both maternal malnutrition and fetal glucocorticoid exposure program increases in arterial pressure in male but not female offspring. While maternal DI increased both superoxide-mediated vasoconstriction and nitric oxide mediated vasodilation, the balance of these factors favored the development of hypertension in males and hypotension in females.
Roghair
Robert D
RD
Dept. of Pediatrics, Univ. of Iowa Carver College of Medicine, Iowa City, 52242, USA. robert-roghair@uiowa.edu
Segar
Jeffrey L
JL
Volk
Kenneth A
KA
Chapleau
Mark W
MW
Dallas
Lindsay M
LM
Sorenson
Anna R
AR
Scholz
Thomas D
TD
Lamb
Fred S
FS
D042842:11-beta-Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000378:metabolism*; D002229:Carbenoxolone / Q000494:pharmacology; D002320:Cardiovascular Physiological Phenomena; D018753:Diet, Protein-Restricted; D004040:Dietary Carbohydrates / Q000494:pharmacology; D005260:Female; D048070:Fetal Nutrition Disorders / Q000378:metabolism; D005938:Glucocorticoids / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000502:physiology; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D011247:Pregnancy; D017382:Reactive Oxygen Species / Q000378:metabolism; D012727:Sex Characteristics; D013152:Splanchnic Circulation / Q000502:physiology; D013481:Superoxides / Q000378:metabolism*; D013686:Telemetry
D004040:Dietary Carbohydrates; D005938:Glucocorticoids; D017382:Reactive Oxygen Species; D013481:Superoxides; D009569:Nitric Oxide; D042842:11-beta-Hydroxysteroid Dehydrogenases; D019001:Nitric Oxide Synthase; D002229:Carbenoxolone